|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.20 SEK | +1.63% |
|
-0.71% | -8.93% |
| 03:20pm | Alligo AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 | CI |
| 11:37am | Alligo AB, Q2 2025 Earnings Call, Jul 17, 2025 |
Summary: Alligo AB
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Highlights: Alligo AB
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses: Alligo AB
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings Chart: Alligo AB
Source: Surperformance
ESG chart: Alligo AB
Source: MSCI
| Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
|---|---|---|---|---|---|
| 571M | |||||
| 52.33B | |||||
| 49.94B | |||||
| - | 9.73B | ||||
| 8.85B | |||||
| 4.82B | |||||
| 1.82B | |||||
| Average | 18.29B | ||||
| Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
A
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
-
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ALLIGO B Stock
- Ratings Alligo AB
Select your edition
All financial news and data tailored to specific country editions
